pI: 4.8988 |
Length (AA): 481 |
MW (Da): 54435 |
Paralog Number:
0
Signal peptide: Y | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
37 | 137 | 5jqp (B) | 34 | 154 | 56.00 | 0 | 1 | 0.501179 | 0.49 |
41 | 134 | 5f0e (B) | 33 | 116 | 57.00 | 0 | 0.94 | 0.609126 | 0.57 |
41 | 80 | 2i1p (A) | 1189 | 1228 | 35.00 | 0 | 0.15 | 0.43386 | -0.59 |
135 | 229 | 2fxm (B) | 866 | 960 | 22.00 | 0 | 0 | 0.468205 | -1.24 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_128657)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G56360 | glucosidase II beta subunit protein PSL4 |
Brugia malayi | Bm1_42055 | protein kinase C substrate 80K-H |
Brugia malayi | Bm1_42060 | glucosidase II beta subunit |
Candida albicans | CaO19.3286 | similar to S. cerevisiae YDR221W |
Candida albicans | CaO19.10796 | similar to S. cerevisiae YDR221W |
Caenorhabditis elegans | CELE_ZK1307.8 | Protein ZK1307.8 |
Dictyostelium discoideum | DDB_G0271120 | hypothetical protein |
Drosophila melanogaster | Dmel_CG6453 | CG6453 gene product from transcript CG6453-RA |
Echinococcus granulosus | EgrG_000532800 | Glucosidase II beta subunit |
Entamoeba histolytica | EHI_135420 | glucosidase 2 subunit beta precursor, putative |
Echinococcus multilocularis | EmuJ_000532800 | Glucosidase II beta subunit |
Homo sapiens | ENSG00000130175 | protein kinase C substrate 80K-H |
Leishmania braziliensis | LbrM.26.1010 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_260970.1 | glucosidase II beta subunit-like protein, putative |
Leishmania infantum | LinJ.26.0970 | hypothetical protein, conserved |
Leishmania major | LmjF.26.1000 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.26.1000 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_02299 | hypothetical protein |
Mus musculus | ENSMUSG00000003402 | protein kinase C substrate 80K-H |
Oryza sativa | 4324264 | Os01g0276800 |
Onchocerca volvulus | OVOC10792 | Glucosidase 2 subunit beta homolog |
Saccharomyces cerevisiae | YDR221W | Gtb1p |
Schistosoma japonicum | Sjp_0205040 | ko:K08288 protein kinase C substrate 80K-H, putative |
Schistosoma mansoni | Smp_131400 | glucosidase II beta subunit |
Schmidtea mediterranea | mk4.001111.01 | Glucosidase 2 subunit beta |
Trypanosoma brucei gambiense | Tbg972.7.890 | protein kinase C substrate protein, heavy chain, putative,glucosidase II beta subunit, putative |
Trypanosoma brucei | Tb927.7.940 | protein kinase C substrate protein, heavy chain, putative |
Trypanosoma congolense | TcIL3000_7_580 | protein kinase C substrate protein, heavy chain, putative |
Trypanosoma cruzi | TcCLB.503463.10 | protein kinase C substrate protein, heavy chain, putative |
Trypanosoma cruzi | TcCLB.508879.4 | protein kinase C substrate protein, heavy chain, putative |
Trypanosoma cruzi | TcCLB.508215.9 | protein kinase C substrate protein, heavy chain, putative |
Trichomonas vaginalis | TVAG_014140 | N-linked oligosaccharide processing, putative |
Trichomonas vaginalis | TVAG_151650 | glucosidase II beta subunit, putative |
Trichomonas vaginalis | TVAG_150160 | glucosidase II beta subunit, putative |
Trichomonas vaginalis | TVAG_173790 | glucosidase II beta subunit, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.7.940 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.7.940 this record | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.7.940 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.7.940 this record | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 3 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | increased (PATO:0000470) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | increased cell proliferation (significant gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.6
1 literature reference was collected for this gene.